Evidence map›Paper›PMID 39034379›Full record

ArticleTranslational stroke research2025

Correction to: Blood DNA Methylation Analysis Reveals a Distinctive Epigenetic Signature of Vasospasm in Aneurysmal Subarachnoid Hemorrhage.

Isabel Fernández-Pérez, Joan Jiménez-Balado, Adrià Macias-Gómez, Antoni Suárez-Pérez, Marta Vallverdú-Prats, Alberto Pérez-Giraldo, Marc Viles-García, Julia Peris-Subiza, Sergio Vidal-Notari, Eva Giralt-Steinhauer and 6 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Translational stroke research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Isabel Fernández-PérezNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Joan Jiménez-BaladoNeurovascular Research Group, Hospital del Mar Medical Research Institute, C/Dr. Aiguader, 88, 08003, Barcelona, Catalunya, Spain. jjimenez3@researchmar.net.
Adrià Macias-GómezNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Antoni Suárez-PérezNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Marta Vallverdú-PratsNeurovascular Research Group, Hospital del Mar Medical Research Institute, C/Dr. Aiguader, 88, 08003, Barcelona, Catalunya, Spain.
Alberto Pérez-GiraldoNeurosurgery Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Marc Viles-GarcíaNeuroradiology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Julia Peris-SubizaNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Sergio Vidal-NotariNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Eva Giralt-SteinhauerNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Daniel Guisado-AlonsoNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Manel EstellerCancer Epigenetics Group, Research Institute Against Leukemia Josep Carreras, Badalona, Catalunya, Spain.
Ana Rodriguez-CampelloNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Jordi Jiménez-CondeNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Angel OisNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.
Elisa Cuadrado-GodiaNeurology Department, Hospital del Mar, Barcelona, Catalunya, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39034379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.